World Vaccine Congress Washington 2022





The World Vaccine Congress is the largest, most established meeting dedicated to vaccines.

From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.


  2023 Early Confirmed Speakers

  • Peter Marks, Director, Center for Biologics Evaluation and Research, FDA
  • Penny Heaton, Global Therapeutic Area Head IDV, Vaccines, Janssen Pharmaceuticals R&D
  • Andrea Carfi, Chief Scientific Officer, Moderna
  • Karin Bok, Acting Deputy Director, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, NIH
  • Rajinder Suri, CEO, DVCMN
  • Bali Pulendran, Professor Microbiology & Immunology, Stanford University
  • Jerome Kim, Director General, IVI
  • Peter Hotez, Dean, National School of Tropical Medicine
  • Matthew Hepburn, Senior Advisor to the OSTP Director on Pandemic Preparedness, Office of Science and Technology Policy
  • Melinda Hamer, Chief, Clinical Trials Center, Walter Reed Army Institute
  • Anna Durbin, Professor, International Health, Director, Center for Immunization Research, Johns Hopkins
  • Brian Abramson Esq., LL.M Treatise Author, Bloomberg Law
  • Charles Kline, Distinguished scientist, CMC Regulatory Affairs Vaccines, Merck
  • Colin Carlson, Assistant Research Professor, Center for Global Health Science & Security, Georgetown University
  • Dana Dallas, Cold Chain & Vaccine Programme Manager, Defence Logistics Agency
  • Daniel Salmon, Director, Institute for Vaccine Safety, Johns Hopkins
  • Daniel Bausch, Senior Director, Emerging Threats and Global Health Security, FIND
  • Eliav Barr, Head, Global Clinical Development and Chief Medical Officer, Merck Research Laboratories
  • Eric Ibsen, CEO, Studylog System Inc
  • Francesca Micoli, Senior Project Leader and Director of Innovation Academy, GSK
  • Grace Chen, Senior Director, Clinical Development, Moderna
  • Greg Poland, Director, Mayo Clinic
  • Hanneke Schuitemaker, VP, J&J
  • Heather Koehler, Assistant professor, School of Molecular Biosciences, Washington State University
  • Jay Berzofsky, Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute, NIH
  • Jim Wassil, COO, Vaxcyte
  • Kathryn Hashey, Global Vaccine Policy & Government Affairs, GSK
  • Katie Atwell, Associate Professor, School of Social Sciences, University of Western Australia
  • Walter Straus, Vice-President, Clinical Safety, Moderna
  • Yoshinobu Nagamine, Senior Donor Manager, GAVI
  • Kerry DeMarco, DRIVe Start Program Innovation & Alliance Manager, BARDA
  • Chris Earnhart, Chief Technology Officer, JPEO CBRND
  • Cristina Casetti, Deputy Director, Division of Microbiology and Infectious Diseases, NIH
  • Amy Jenkins, Program Manager, DARPA
  • Sandeep Patel, Director DRIVe, BARDA
  • Paula Barbosa, Associate Director, IFPMA
  • Alexandra Bhatti, Director, US Vaccine Public Policy, Merck
  • Jon Heinrichs, Assoc. VP, Global Lead, Sanofi
  • Saad Omer, Director, Yale School of Medicine
  • Rebecca Chandler, Clinical Development Vaccine Safety Lead, CEPI
  • Joe Smyser, CEO, Public Good Projects
  • John Mascola, CSO, ModeX
  • Jolieke Van Oosterwijk, Chief Scientific Officer, US Biologics
  • Katya Vert-Wong, Vice President of Research & Development Operations, Sabin Vaccine Institute
  • Kayvon Modjarrad, Director, Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research
  • Kutub Mahmood, Director, PATH
  • Lora Shimp, Director Immunization Centre, John Snow Institute
  • Mahesh Kumar, SVP, Zoetis
  • Maria Van Kerkhove, Infectious Disease Epidemiologist; COVID-19 Technical Lead, WHO
  • Mark Schleiss, Professor in Paediatrics, University of Minnesota
  • Michael Schrader, CEO, Vaxess Technologies
  • Michael Ciesielski, CEO, MimiVax
  • Michael Merchilinsky, Scientific Program Manager, BARDA
  • Mike Osterholm, Director, University of Minnesota
  • Mohit Chopra, COVID-19 Vaccine Project Lead, J &J
  • Nicole Dorsey, Director, JPEO-CBRND
  • Niranjan Sardesai, CEO, Geneos Therapeutics
  • Nora Disis, CVI Director, Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynaecology, UW Medicine
  • Robert Chen, Scientific Director, Brighton Collaboration
  • Robin Levis, Deputy Director, Division of Viral Products, FDA
  • Scott Gallichan, Senior Director, Sanofi
  • Sonali Kochhar, Clinical Associate Professor, Department of Global Health, University of Washington
  • Thomas Linglebach, CEO, Valneva

Covering All the Important Topics


Covid & Beyond




Emerging & Infectious Diseases

Clinical Trials

Bioprocessing & Manufacturing




Vaccine Safety


Supply & Logistics

Market Access



“This was a great conference. You and your team have made an important contribution to mankind over the years, and I salute you at this time of Force Majeure.”

- Avril Biopharma
"WVC is the only scientific forum that I know of that focuses on vaccine safety across the biomedical research communities."

- Moderna Therapeutics
”Congratulations on organizing and executing an excellent virtual WVC. The topics and speakers were excellent and the virtual user experience was seamless.“




Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.